Abstract
We have taken the first steps towards a complete reconstruction of the Mycobacterium tuberculosis regulatory network based on ChIP-Seq and combined this reconstruction with system-wide profiling of messenger RNAs, proteins, metabolites and lipids during hypoxia and re-aeration. Adaptations to hypoxia are thought to have a prominent role in M. tuberculosis pathogenesis. Using ChIP-Seq combined with expression data from the induction of the same factors, we have reconstructed a draft regulatory network based on 50 transcription factors. This network model revealed a direct interconnection between the hypoxic response, lipid catabolism, lipid anabolism and the production of cell wall lipids. As a validation of this model, in response to oxygen availability we observe substantial alterations in lipid content and changes in gene expression and metabolites in corresponding metabolic pathways. The regulatory network reveals transcription factors underlying these changes, allows us to computationally predict expression changes, and indicates that Rv0081 is a regulatory hub.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Quantitative prediction of conditional vulnerabilities in regulatory and metabolic networks using PRIME
npj Systems Biology and Applications Open Access 06 December 2021
-
Interception of host fatty acid metabolism by mycobacteria under hypoxia to suppress anti-TB immunity
Cell Discovery Open Access 05 October 2021
-
Early phase of effective treatment induces distinct transcriptional changes in Mycobacterium tuberculosis expelled by pulmonary tuberculosis patients
Scientific Reports Open Access 08 September 2021
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Rent or buy this article
Get just this article for as long as you need it
$39.95
Prices may be subject to local taxes which are calculated during checkout




References
Manabe, Y. C. & Bishai, W. R. Latent Mycobacterium tuberculosis-persistence, patience, and winning by waiting. Nature Med. 6, 1327–1329 (2000)
Flynn, J. L. & Chan, J. Tuberculosis: latency and reactivation. Infect. Immun. 69, 4195–4201 (2001)
Schnappinger, D. et al. Transcriptional adaptation of Mycobacterium tuberculosis within macrophages: insights into the phagosomal environment. J. Exp. Med. 198, 693–704 (2003)
Yang, X., Nesbitt, N. M., Dubnau, E., Smith, I. & Sampson, N. S. Cholesterol metabolism increases the metabolic pool of propionate in Mycobacterium tuberculosis . Biochemistry 48, 3819–3821 (2009)
Miner, M. D., Chang, J. C., Pandey, A. K., Sassetti, C. M. & Sherman, D. R. Role of cholesterol in Mycobacterium tuberculosis infection. Indian J. Exp. Biol. 47, 407–411 (2009)
Chang, J. C. et al. igr genes and Mycobacterium tuberculosis cholesterol metabolism. J. Bacteriol. 191, 5232–5239 (2009)
Daniel, J., Maamar, H., Deb, C., Sirakova, T. D. & Kolattukudy, P. E. Mycobacterium tuberculosis uses host triacylglycerol to accumulate lipid droplets and acquires a dormancy-like phenotype in lipid-loaded macrophages. PLoS Pathog. 7, e1002093 (2011)
Low, K. L. et al. Triacylglycerol utilization is required for regrowth of in vitro hypoxic nonreplicating Mycobacterium bovis bacillus Calmette-Guerin. J. Bacteriol. 191, 5037–5043 (2009)
Russell, D. G., Mwandumba, H. C. & Rhoades, E. E. Mycobacterium and the coat of many lipids. J. Cell Biol. 158, 421–426 (2002)
Robertson, G. et al. Genome-wide profiles of STAT1 DNA association using chromatin immunoprecipitation and massively parallel sequencing. Nature Methods 4, 651–657 (2007)
Mikkelsen, T. S. et al. Genome-wide maps of chromatin state in pluripotent and lineage-committed cells. Nature 448, 553–560 (2007)
Johnson, D. S., Mortazavi, A., Myers, R. M. & Wold, B. Genome-wide mapping of in vivo protein-DNA interactions. Science 316, 1497–1502 (2007)
Ehrt, S. et al. Controlling gene expression in mycobacteria with anhydrotetracycline and Tet repressor. Nucleic Acids Res. 33, e21 (2005)
Ehrt, S. & Schnappinger, D. Controlling gene expression in mycobacteria. Future Microbiol. 1, 177–184 (2006)
Klotzsche, M., Ehrt, S. & Schnappinger, D. Improved tetracycline repressors for gene silencing in mycobacteria. Nucleic Acids Res. 37, 1778–1788 (2009)
Farnham, P. J. Insights from genomic profiling of transcription factors. Nature Rev. Genet. 10, 605–616 (2009)
MacQuarrie, K. L., Fong, A. P., Morse, R. H. & Tapscott, S. J. Genome-wide transcription factor binding: beyond direct target regulation. Trends Genet. 27, 141–148 (2011)
Galagan, J., Lyubetskaya, A. & Gomes, A. ChIP-Seq and the complexity of bacterial transcriptional regulation. Curr. Top. Microbiol. Immunol. 363, 43–68 (2013)
Chauhan, S., Sharma, D., Singh, A., Surolia, A. & Tyagi, J. S. Comprehensive insights into Mycobacterium tuberculosis DevR (DosR) regulon activation switch. Nucleic Acids Res. 39, 7400–7414 (2011)
Gautam, U. S., Chauhan, S. & Tyagi, J. S. Determinants outside the DevR C-terminal domain are essential for cooperativity and robust activation of dormancy genes in Mycobacterium tuberculosis . PLoS ONE 6, e16500 (2011)
Vasudeva-Rao, H. M. & McDonough, K. A. Expression of the Mycobacterium tuberculosis acr-coregulated genes from the DevR (DosR) regulon is controlled by multiple levels of regulation. Infect. Immun. 76, 2478–2489 (2008)
Cho, B. K., Federowicz, S., Park, Y. S., Zengler, K. & Palsson, B. O. Deciphering the transcriptional regulatory logic of amino acid metabolism. Nature Chem. Biol. 8, 65–71 (2012)
Colangeli, R. et al. The multifunctional histone-like protein Lsr2 protects mycobacteria against reactive oxygen intermediates. Proc. Natl Acad. Sci. USA 106, 4414–4418 (2009)
Gordon, B. R. et al. Lsr2 is a nucleoid-associated protein that targets AT-rich sequences and virulence genes in Mycobacterium tuberculosis . Proc. Natl Acad. Sci. USA 107, 5154–5159 (2010)
Rustad, T. R., Harrell, M. I., Liao, R. & Sherman, D. R. The enduring hypoxic response of Mycobacterium tuberculosis . PLoS ONE 3, e1502 (2008)
Kendall, S. L. et al. A highly conserved transcriptional repressor controls a large regulon involved in lipid degradation in Mycobacterium smegmatis and Mycobacterium tuberculosis . Mol. Microbiol. 65, 684–699 (2007)
Nesbitt, N. M. et al. A thiolase of Mycobacterium tuberculosis is required for virulence and production of androstenedione and androstadienedione from cholesterol. Infect. Immun. 78, 275–282 (2010)
Gao, C. H., Yang, M. & He, Z. G. Characterization of a novel ArsR-like regulator encoded by Rv2034 in Mycobacterium tuberculosis . PLoS ONE 7, e36255 (2012)
Gonzalo-Asensio, J. et al. PhoP: a missing piece in the intricate puzzle of Mycobacterium tuberculosis virulence. PLoS ONE 3, e3496 (2008)
Gonzalo Asensio, J. et al. The virulence-associated two-component PhoP-PhoR system controls the biosynthesis of polyketide-derived lipids in Mycobacterium tuberculosis . J. Biol. Chem. 281, 1313–1316 (2006)
Ryndak, M., Wang, S. & Smith, I. PhoP, a key player in Mycobacterium tuberculosis virulence. Trends Microbiol. 16, 528–534 (2008)
Abramovitch, R. B., Rohde, K. H., Hsu, F. F. & Russell, D. G. aprABC: a Mycobacterium tuberculosis complex-specific locus that modulates pH-driven adaptation to the macrophage phagosome. Mol. Microbiol. 80, 678–694 (2011)
Singh, A. et al. Mycobacterium tuberculosis WhiB3 maintains redox homeostasis by regulating virulence lipid anabolism to modulate macrophage response. PLoS Pathog. 5, e1000545 (2009)
Ernst, J., Vainas, O., Harbison, C. T., Simon, I. & Bar-Joseph, Z. Reconstructing dynamic regulatory maps. Mol. Syst. Biol. 3, 74 (2007)
Garton, N. J. et al. Cytological and transcript analyses reveal fat and lazy persister-like bacilli in tuberculous sputum. PLoS Med. 5, e75 (2008)
Park, H. D. et al. Rv3133c/dosR is a transcription factor that mediates the hypoxic response of Mycobacterium tuberculosis . Mol. Microbiol. 48, 833–843 (2003)
Baek, S. H., Li, A. H. & Sassetti, C. M. Metabolic regulation of mycobacterial growth and antibiotic sensitivity. PLoS Biol. 9, e1001065 (2011)
Cox, J. S., Chen, B., McNeil, M. & Jacobs, W. R., Jr Complex lipid determines tissue-specific replication of Mycobacterium tuberculosis in mice. Nature 402, 79–83 (1999)
Camacho, L. R., Ensergueix, D., Perez, E., Gicquel, B. & Guilhot, C. Identification of a virulence gene cluster of Mycobacterium tuberculosis by signature-tagged transposon mutagenesis. Mol. Microbiol. 34, 257–267 (1999)
Converse, S. E. et al. MmpL8 is required for sulfolipid-1 biosynthesis and Mycobacterium tuberculosis virulence. Proc. Natl Acad. Sci. USA 100, 6121–6126 (2003)
Domenech, P. et al. The role of MmpL8 in sulfatide biogenesis and virulence of Mycobacterium tuberculosis . J. Biol. Chem. 279, 21257–21265 (2004)
Rousseau, C. et al. Production of phthiocerol dimycocerosates protects Mycobacterium tuberculosis from the cidal activity of reactive nitrogen intermediates produced by macrophages and modulates the early immune response to infection. Cell. Microbiol. 6, 277–287 (2004)
Nazarova, E. V. et al. Role of lipid components in formation and reactivation of Mycobacterium smegmatis “nonculturable” cells. Biochemistry 76, 636–644 (2011)
Ojha, A. K. et al. Growth of Mycobacterium tuberculosis biofilms containing free mycolic acids and harbouring drug-tolerant bacteria. Mol. Microbiol. 69, 164–174 (2008)
Ojha, A. K., Trivelli, X., Guerardel, Y., Kremer, L. & Hatfull, G. F. Enzymatic hydrolysis of trehalose dimycolate releases free mycolic acids during mycobacterial growth in biofilms. J. Biol. Chem. 285, 17380–17389 (2010)
Arnvig, K. & Young, D. Non-coding RNA and its potential role in Mycobacterium tuberculosis pathogenesis. RNA Biol. 9, 427–436 (2012)
Acknowledgements
This project has been funded in whole or in part with Federal funds from the National Institute of Allergy and Infectious Diseases National Institute of Health, Department of Health and Human Services, under contract no. HHSN272200800059C and U19 AI 076217, R01 AI 071155, the Paul G. Allen Family Foundation (to DRS), the National Science Foundation Pre-doctoral Fellowship Program (to K.M.), and the Burroughs Wellcome Fund Award for Translational Research. We acknowledge D. C. Young for lipidomics mass spectrometry services and advice. We would also like to thank L. Carvalho for his advice on the statistical analysis of the gene expression modelling. We are grateful for the administrative assistance of S. Shiviah and S. Tucker and for the support and advice of V. Di Francesco, K. Lacourciere, P. Dudley and M. Polanski.
Author information
Authors and Affiliations
Contributions
J.E.G. led the project with G.K.S., oversaw ChIP-Seq, wrote the paper and produced figures, discussed results and implications, oversaw data integration, and performed analyses. K.M. co-designed and performed ChIP and transcriptomic experiments, discussed results and implications, and commented on the manuscript. M.P. developed the analysis pipeline for ChIP-Seq data, performed all ChIP-Seq data analysis, and contributed multiple figures and text. A.L. performed all analysis of the integration of TF induction transcriptomics with ChIP-Seq data, contributed to analysis of ChIP-Seq binding data, and contributed multiple figures and text. E.A. developed the predictive models of gene expression, and contributed all corresponding figures and text. L.S. performed lipidomics experiments and data analysis, discussed the results and implications, and contributed figure and text to the paper. A.G. developed the improved blind deconvolution algorithm for ChIP-Seq, contributed to analysis of all ChIP-Seq data, and contributed corresponding figures. T.R. designed and performed hypoxic time course and transcriptomic experiments, discussed results and implications and commented on the manuscript. G.D. performed all RT–PCR transcriptomics experiments and contributed analyses to the paper. I.G. performed the DREM analysis and provided corresponding the figure. T.A. analysed ChIP-Seq data, developed the interfaces for data sharing and public release, and provided text. C.M. performed all library preparation and sequencing for ChIP-Seq. A.D.K. performed the metabolomics measurements, data analysis and their interpretation, discussed the results and implications and commented on the manuscript. R.A. was responsible for overview of bioinformatics and statistical data analysis. W.B. performed hypoxic time course, ChIP and transcriptomic experiments, and discussed results and implications. A.K. performed the experimental analysis of KstR de-repression and provided the corresponding figure. S.J. performed the experimental analysis of KstR de-repression, and provided the corresponding figure. M.J.H. produced individual MTB strains for ChIP-Seq experiments, and discussed results and implications. J.Z. developed and curated the MTB metabolic model. C.G. contributed to analysis of profiling data. J.K.W. performed ChIP and transcriptomic experiments, and discussed results and implications. Y.V.P. provided support and advice. P.I. contributed to the analysis of KstR expression and the validation of KstR binding sites. B.W. contributed to the ChIP-Seq analysis pipeline. P.S. and C.S. developed the interfaces for data sharing and public release. D.C. contributed to initial network analysis. J.D. contributed to analysis of profiling data. Y.L. contributed expression data for TB under different lipids. P.D. was responsible for experimental design and mass spectrometry analysis. J.L. was responsible for coordinating sample analysis, data generation, annotation and results reporting Y.Z. was responsible for proteomics statistical data analysis. J.P. was responsible for analysis of LC-MS and LC-MS/MS data analysis, protein identification and maintenance of annotation databases. A.D. and H.-J.M. discussed the results and implications and commented on the manuscript. B.H. and W.-H.Y. developed the ChIP protocol; S.T.P. developed the ChIP protocol, performed the KstR RT–PCR experiments, and performed the MTB KstR native promoter ChIP-Seq experiments. S.R. developed the ChIP protocol, oversaw experimental work on KstR and commented on the manuscript. S.H.E.K. discussed the results and implications and commented on the manuscript. R.P.M. performed the metabolomics measurements, data analysis, and their interpretation; discussed the results and implications and commented on the manuscript. D.C. was responsible for overall scientific direction of the proteomic core. D.B.M. oversaw lipidomics experiments, contributed to integration of methods across mass spectral platforms, discussed the results and implications and commented on the manuscript. D.R.S. oversaw the hypoxic culture, ChIP and transcriptomic experiments, discussed results and implications, provided text and commented extensively on the manuscript. G.K.S. led the project with J.E.G., oversaw RT–PCR experiments, discussed results and implications, provided text and commented extensively on the manuscript. G.K.S. and D.R.S. are co-last authors.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Supplementary information
Supplementary Information
This file contains Supplementary Text and Methods, Supplementary Figures 1-29, Supplementary Tables 1-5 and Supplementary References. (PDF 9391 kb)
Supplementary Data
This file contains a summary table of MTB TFs mapped using Chip-Seq. (PDF 1338 kb)
Supplementary Data
This zipped file contains a Cytoscape file containing MTB metabolic network reconstruction. (ZIP 586 kb)
Supplementary Data
This zipped file contains a Cytoscape file containing MTB regulatory network model. (ZIP 908 kb)
Rights and permissions
About this article
Cite this article
Galagan, J., Minch, K., Peterson, M. et al. The Mycobacterium tuberculosis regulatory network and hypoxia. Nature 499, 178–183 (2013). https://doi.org/10.1038/nature12337
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/nature12337
This article is cited by
-
Types and functions of heterogeneity in mycobacteria
Nature Reviews Microbiology (2022)
-
Environment dependent expression of mycobacterium hormone sensitive lipases: expression pattern under ex-vivo and individual in-vitro stress conditions in M. tuberculosis H37Ra
Molecular Biology Reports (2022)
-
Genome-scale analyses of transcriptional start sites in Mycobacterium marinum under normoxic and hypoxic conditions
BMC Genomics (2021)
-
Quantitative prediction of conditional vulnerabilities in regulatory and metabolic networks using PRIME
npj Systems Biology and Applications (2021)
-
Identification of a PadR-type regulator essential for intracellular pathogenesis of Burkholderia pseudomallei
Scientific Reports (2021)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.